Education
About Us
Working with TipRanks
Follow Us
Proteome Sciences (DE:PI2)
:PI2
Total Valuation
Proteome Sciences has a market cap or net worth of €9.53M. The enterprise value is €22.74M.
Market Cap€9.53M
Enterprise Value€22.74M
Share Statistics
Proteome Sciences has 295,182,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding295,182,040
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Proteome Sciences’s return on equity (ROE) is 0.80 and return on invested capital (ROIC) is -15.13%.
Return on Equity (ROE)0.80
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-15.13%
Return on Capital Employed (ROCE)1.60
Revenue Per Employee139.67K
Profits Per Employee-67.86K
Employee Count36
Asset Turnover0.44
Inventory Turnover4.04
Valuation Ratios
The current PE Ratio of Proteome Sciences is -5.46. Proteome Sciences’s PEG ratio is 0.02.
PE Ratio-5.46
PS Ratio0.00
PB Ratio-4.35
Price to Fair Value-4.35
Price to FCF-18.57
Price to Operating Cash Flow-27.72
PEG Ratio0.02
Income Statement
In the last 12 months, Proteome Sciences had revenue of 5.03M and earned -2.44M in profits. Earnings per share was -0.01.
Revenue5.03M
Gross Profit1.65M
Operating Income-1.62M
Pretax Income-2.42M
Net Income-2.44M
EBITDA-1.14M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -8.96B and capital expenditures -1.72B, giving a free cash flow of -10.68B billion.
Operating Cash Flow-8.96B
Free Cash Flow-10.68B
Free Cash Flow per Share-36.18
Dividends & Yields
Proteome Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change-40.00%
50-Day Moving Average0.04
200-Day Moving Average0.03
Relative Strength Index (RSI)31.93
Average Volume (3m)0.00
Important Dates
Proteome Sciences upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.
Last Earnings DateApr 10, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
Proteome Sciences as a current ratio of 0.33, with Debt / Equity ratio of -258.66%
Current Ratio0.33
Quick Ratio0.27
Debt to Market Cap0.84
Net Debt to EBITDA-10.07
Interest Coverage Ratio-2.03
Taxes
In the past 12 months, Proteome Sciences has paid 25.00K in taxes.
Income Tax25.00K
Effective Tax Rate-0.01
Enterprise Valuation
Proteome Sciences EV to EBITDA ratio is -21.80, with an EV/FCF ratio of -34.52.
EV to Sales4.93
EV to EBITDA-21.80
EV to Free Cash Flow-34.52
EV to Operating Cash Flow-51.52
Balance Sheet
Proteome Sciences has €1.21M in cash and marketable securities with £127.18B in debt, giving a net cash position of €12.41M billion.
Cash & Marketable Securities€1.21M
Total Debt£127.18B
Net Cash€12.41M
Net Cash Per Share€0.04
Tangible Book Value Per Share-€0.02
Margins
Gross margin is 99.96%, with operating margin of -32.24%, and net profit margin of -48.59%.
Gross Margin99.96%
Operating Margin-32.24%
Pretax Margin-48.09%
Net Profit Margin-48.59%
EBITDA Margin-22.61%
EBIT Margin-32.24%
Analyst Forecast
The average price target for Proteome Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―